Abstract
Modern prospective trials have recently shown that warfarin prescribed to produce less anticoagulant effect than was customary in the past reduces cardioembolic stroke by up to 80% in patients with nonvalvular atrial fibrillation. These results represent a major advance in stroke prevention. The effectiveness of antithrombotic treatment in other settings in which there is risk of cardioembolism is less well established but likely to be substantial.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 67-72+77 |
| Journal | Postgraduate medicine |
| Volume | 90 |
| Issue number | 8 |
| DOIs | |
| State | Published - 1991 |
